Repository logo

Browsing by Issue Date, starting with "2023-10-21"

Filter results by year or month
Now showing 1 - 2 of 2
  • Wild mushrooms for Alzheimer’s disease
    Publication . Silva, Margarida Lobo; Reis, Filipa S.; Grosso, Clara; Pérez, Diana Valverde; Barros, Lillian; Martins, Rosário
    Alzheimer’s disease (AD) is among the most incident, debilitating, and widespread forms of dementia. AD causes the decline of cognitive function, making overall day-to-day tasks difficult and even impossible. Despite extensive research, its origin and progression are still unclear, and no efficient treatment is available to prevent disease progression or mitigate symptoms. Due to the low efficiency in the available treatments, natural compounds have arisen as an alternative. These are gaining crescent relevance and have been explored, given their promising results as immunomodulatory, anti-inflammatory, or neuroprotective factors. Mountain natural resources, specifically mushrooms, are among the most studied sources of bioactive molecules. The Montesinho Natural Park, located in northeast Portugal, has incredible mushroom biodiversity, which has been exploited to obtain health-beneficial compounds, namely with anti-inflammatory potential. This work aimed to study different mushroom extracts and isolated compounds for the prevention and progression of AD. So far, our work aimed at bringing insight into the effect of extract administration in neuroblastoma and endothelial cell lines through the MTT viability assay, as well as studying their effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), enzymes known to be involved in AD pathogenesis through a modified Ellman’s method: dry extracts were resuspended in tris-HCl 50mM + 10% DMSO to concentrations between 2 and 0.03125 mg/mL for enzymatic inhibition assays. To be considered promising, extracts must not cause cellular death of over 15-20% and cause enzymatic inhibition. So far, our results using nine mushroom extracts show low-to-no cytotoxicity in concentrations between 100 and 6.25 µg/mL in endothelial and neuroblastoma cell lines. High concentrations of Lycoperdon umbrinum extract caused cytotoxicity levels of approximately 35% in endothelial cells after 24h treatment; different extracts caused cell proliferation in both cell lines, the most evident being 128% in the lowest concentrations of Russula delica and Boletus fragrans. The most promising results were obtained for Boletus aereus, which, while not cytotoxic, inhibited both enzymes by 60%. Around 30% AChE inhibition was achieved for the two highest concentrations of Agaricus silvicola and Boletus fragrans making both extracts good candidates for further studies.
    2023-10-21Conference object Open access Show more
  • Essential trace elements status in portuguese pregnant women and their association with maternal and neonatal outcomes: A prospective study from the IoMum Cohort
    Publication . Bracchi, Isabella; Guimarães, Juliana; Rodrigues, Catarina; Azevedo, Rui; Coelho, Cláudia Matta; Pinheiro, Cátia; Morais, Juliana; Barreiros-Mota, Inês; Fernandes, Virgínia Cruz; Delerue-Matos, Cristina; Pinto, Edgar; Moreira-Rosário, André; Azevedo, Luís Filipe Ribeiro de; Dias, Cláudia Camila; Lima, Jorge; Sapinho, Inês; Ramalho, Carla; Calhau, Conceição; Leite, João Costa; Almeida, Agostinho; Pestana, Diogo; Keating, Elisa
    Cobalt (Co), copper (Cu), manganese (Mn), molybdenum (Mo), and zinc (Zn) are essential trace elements (ETEs) important in cellular chemical reactions and antioxidant defense. Ingestion of ETEs during pregnancy is crucial but their role in specific pregnancy outcomes is largely unknown. This study aimed to quantify urinary levels of these ETEs in pregnancy and to evaluate their role in pregnancy health. First trimester pregnant women of Porto and Lisbon regions provided a urine sample, and sociodemographic and lifestyle data. Clinical data were obtained from clinical records. Urinary ETEs were quantified by inductively coupled plasma mass spectrometry (ICP-MS). Our results show that having urinary Zn levels above the 50th percentile (P50) increases the risk of pre-eclampsia (PE). On the other hand, urinary Zn levels above the P50 decreased the risk of being born with head circumference small for gestational age but it increased the risk having length small for gestational age at birth. This study may provide valuable information for public health policies related to prenatal nutrition, while informing future efforts to de-fine urinary reference intervals for ETEs in pregnant women
    2023-10-21Journal article Open access Show more